IBM Big Data Hub

AUGUST 7, 2023

Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. The ability to seize these advantages is one way that pharmaceutical companies may be able to gain sizable competitive edge.

Healthcare 56

Healthcare Artificial Intelligence Data science Compliance 56

Reltio

SEPTEMBER 13, 2022

The study reported that a composite customer investing in Reltio's MDM solution achieved a 366% return on investment (ROI) and a total net present value of $13 million over three years, with a payback on their investment within six months once operational.

MDM 52

MDM B2C IT B2B 52

Hunton Privacy

NOVEMBER 10, 2016

The impetuses for the survey were the many significant changes the GDPR will bring to companies’ management and processing of personal data, their privacy compliance programs and their IT systems and infrastructure. The survey questions focused on the GDPR topics most relevant to everyday business and compliance concerns.

GDPR 45

GDPR Data Privacy Compliance Privacy 45

DLA Piper Privacy Matters

JANUARY 11, 2021

The proposal harmonises both requirements and adds a list of measures that should at a minimum be present. Management bodies of essential and important entities will have to approve these cybersecurity risk management measures, supervise their implementation and be accountable for non-compliance by the entity.

Cybersecurity 91

Cybersecurity Computer and Electronics Manufacturing Cloud 91

Hunton Privacy

MARCH 23, 2010

The agents had been authorized by a lower court judge to inspect the emails pursuant to an investigation into an alleged abuse of dominant position in the pharmaceutical market. The Court’s decision in the Janssen-Cilag case is available (in French) on legalis.net.

Privacy 40

Privacy Healthcare Personal data Compliance 40

Data Matters

JANUARY 2, 2018

At present, litigation of this type has typically failed at the pleadings stage due to plaintiffs’ failure to demonstrate the “injury in fact” necessary for Article III standing. China’s recent steps follow other countries in imposing new regulatory standards that will authorize intrusive government compliance reviews.

Cybersecurity 68

Cybersecurity Privacy Data breaches GDPR 68

IT Governance

DECEMBER 27, 2019

Some commenters, like Senior Consultancy Manager Nicky Whiting, found that organisations had become complacent about their GDPR compliance requirements. Many people speculated that Huawei’s close ties with the Chinese government presented security risks, and thus the organisation should only be used for “non-core” parts of the system.

Data breaches 69

Data breaches GDPR Passwords Personal data 69